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Highly pathogenic avian influenza (HPAI) viruses cause viraemia and systemic infections with virus
replication in internal organs and muscles; in contrast, low pathogenicity avian influenza (LPAI) viruses
produce mild infections with low mortality rates and local virus replication. There is little available
information on the ability of LPAI viruses to cause viraemia or on the presence of avian influenzaviruses in
general in the muscles of infected turkeys. The aim of the present study was to determine the ability of LPAI
and HPAI H7N1 viruses to reach muscle tissues following experimental infection and to determine the
efficacy of vaccination in preventing viraemia and meat localization. The potential of infective muscle tissue
to act as a source of infection for susceptible turkeys by mimicking the practice of swill-feeding was also
investigated. The HPAI virus was isolated from blood and muscle tissues of all unvaccinated turkeys; LPAI
could be isolated only from blood of one bird and could be detected only by reverse transcriptase-
polymerase chain reaction in muscles. In contrast, no viable virus or viral RNA could be detected in muscles
of vaccinated/challenged turkeys, indicating that viral localization in muscle tissue is prevented in vaccinated
birds.
Introduction
Avian influenza (AI) represents one of the major
concerns for public health that has emerged in recent
times. Over the past decade a sharp increase in the
number of outbreaks in birds, especially poultry, has
occurred, with a high economic impact on the commer-
cial poultry sector. Moreover, fears about the potential
zoonotic risk have concurred to reduce market demand
for poultry products, both in affected countries and in
non-affected countries, increasing the crisis for the
poultry industry and affecting employment rates in
some countries (Doyle & Erickson, 2006).
The occurrence of major AI outbreaks between 1999
and 2004, caused by viruses of the H7 subtype, have
stimulated the revision of the definition of AI for
statutory and trade purposes (Capua & Alexander,
2006). One of the main changes in current European
Union legislation and in World Organization for Animal
Health (OIE) guidelines is that the use of vaccination is
seen as a potentially useful aid in the control of AI
infections.
The issue of trading meat, obtained from vaccinated
animals, has been the subject of international debate for
a significant amount of time, and the consensus reached
is that meat and products obtained from vaccinated
animals can be traded, provided the animals can be
shown not to be infected at the time of slaughter.
Although several systems exist to differentiate infected
from vaccinated animals (Capua & Cattoli, 2007), a risk
that a vaccinated/infected flock may escape surveillance
systems in place cannot be ruled out, particularly during
the early phases of infection. This raises concerns for the
role that potentially infected meat may play in the spread
of infection to avian and non-avian hosts.
In addition to the H7N1 and H7N3 epidemic waves of
1999 to 2003, ongoing surveillance programmes in Italy
have shown that low pathogenicity avian influenza
(LPAI) viruses of the H7 subtype appear to be prevalent
in the wild bird population and have also been detected
in backyard flocks (Terregino et al., 2007). Field and
laboratory evidence indicates that turkeys are particu-
larly susceptible to AI virus infections (Werner et al.,
2000; Capua et al., 2003; Tumpey et al., 2004; McNally
et al., 2006), requiring minimal doses of field virus to
develop infection.
Highly pathogenic avian influenza (HPAI) virus
infections in Galliformes species produce a systemic
*To whom correspondence should be addressed. Tel: 39 49 8084371. Fax: 39 49 8084360. E-mail: icapua@izsvenezie.it
Received 6 September 2007
Avian Pathology (August 2008) 37(4), 407412
ISSN 0307-9457 (print)/ISSN 1465-3338 (online)/08/40407-06 # 2008 Houghton Trust Ltd
DOI: 10.1080/03079450802061124disease causing viraemia with viral replication and
localization in organs and muscles (Mo et al., 1997;
Perkins & Swayne, 2001; Starick & Werner, 2003;
Swayne & Beck, 2005). In contrast, LPAI virus infec-
tions usually cause milder conditions, which can be
complicated by other pathogens (Capua & Marangon,
2000; Kishida et al., 2004). For LPAI viruses, viral
replication is allegedly restricted to the respiratory and
gastrointestinal tracts (Alexander, 2000), but little is
known on the ability of these viruses to replicate in other
tissues and organs including muscles. For this reason we
carried out an investigation to detect the presence of
viral RNA and live virus in meat collected from
vaccinated and unvaccinated turkeys experimentally
infected with HPAI and LPAI viruses of the H7 subtype.
Additional information on the risk posed by infected
meat on spread of infection through swill feeding was
also generated.
Materials and Methods
Vaccine and vaccination scheme. Chickens and turkeys were immunized
with a commercially available inactivated bivalent vaccine containing
the following strains: H5N9 LPAI (A/chicken/Italy/22A/1998) and
H7N1 LPAI (A/chicken/Italy/1067/1999). The vaccination scheme
consisted of two doses of 0.5 ml administered by the subcutaneous
route in the back of the neck at 19 days of age and 3 weeks later (at
40 days of age). Both chickens and turkeys were given the same
vaccination protocol.
Serum samples collected from vaccinated birds before each vaccina-
tion and before challenge were tested by haemagglutination inhibition
(HI) tests for antibodies to the H7 subtype. The log2 geometric mean
titre of the serum of vaccinated turkeys was calculated.
Viruses. Experimental infection of turkeys was carried out with two
H7N1 viruses: A/turkey/Italy/3675/1999 (LPAI) and A/turkey/Italy/
4580/1999 (HPAI).
Viruses were titrated in 9-day-old to 10-day-old embryonated eggs
from specific pathogen free (SPF) domestic fowls, using 10-fold
dilutions and five eggs per dilution. The median egg infectious dose
(EID50) was calculated according to the Reed and Muench formula
(Reed & Muench, 1938).
Experimental Design
Animals. Commercially available 1-day-old poults were used in this
study. Experimental birds originating from a parent flock that was
serologically negative by agar gel immunodiffusion (AGID) test and
enzyme-linked immunosorbent assay (ELISA) tests and by real-time
reverse transcriptase-polymerase chain reaction (RRT-PCR) on cloacal
swabs were used. One-day-old SPF chicks were used in the swill-feeding
experiment.
All animals were identified by means of wing tags and received feed
and water ad libitum. Birds were housed in negative-pressure, high-
efficiency particulate air-filtered isolation cabinets for the duration of
the experimental trial.
Assessment of viral presence in muscles. Two groups of 15 vaccinated
poults 6 to 7 weeks old and two groups of 15 unvaccinated hatch mates
were used in the experimental trial. At 50 days of age (10 days after the
second vaccination) all experimental groups were given 100 ml challenge
virus containing 10
6 EID50 oro-nasally. For clarity, each of the two
challenge viruses was given to one vaccinated group and one unvacci-
nated group.
On days 1, 2, 3, 4 and 5 post infection (p.i.), bloodwas collected from
each bird from the wing vein, mixed with anticoagulant (Alsever’s
solution 1:1) and the establishment of viraemia was evaluated by RRT-
PCR. If blood samples yielded positive results, up to three birds from
each group presenting viraemia were killed humanely on the day of
testing. When blood samples yielded negative results and no animals
showed clinical signs, three turkeys were killed humanely on a random
basis; otherwise, those presenting clinical signs were sacrificed. In the
case of any death, organs were collected on the day of death. Lungs,
superficial and deep pectoral muscles and thigh muscles were collected
from each killed or naturally deceased turkey.
Avian influenza transmission-feeding test. For this experimental trial,
two groups of five 7-week-old SPF chickens and two groups of five
turkeys of the same age were used. One group of chickens and one
group of turkeys were vaccinated as described above and two groups
were left unvaccinated.
At 50 days of age, experimental groups of birds were fed with a meat
homogenate prepared as described below and were observed daily for
clinical signs. Tracheal and cloacal swabs were collected on days 3, 5 and
7 after administration of the homogenate. Serum samples were also
collected on 7, 14 and 21 days post administration of the homogenate.
The infective meat homogenate was prepared with meat samples
positive by virus isolation (VI) collected from unvaccinated turkeys
infected with the HPAI virus. Muscles that yielded the highest viral
titres were homogenized together with sterile quartz sand. The meat
homogenate was further titrated in embryonated SPF eggs to ascertain
the infectious dose. Two grams of the infective meat homogenate with a
viral titre of 10
3.6 EID50/0.1g were administered to each animal by the
oral route. The infective meat homogenate was introduced directly into
the oesophagus with a syringe in order to reduce the risk of inhalation
and to ascertain the ingestion of the whole sample.
Virus isolation. The organs collected were weighed (1 g) and homo-
genized with sterile quartz sand and phosphate-buffered solution (PBS)
containing antibiotics and 20% glycerol (v/v) to make a 1:10 (w/v)
suspension. Blood samples, collected for the evaluation of viraemia,
were diluted 1:10 in PBS containing antibiotics to avoid the embryo
toxicity of the anticoagulant. Tracheal and cloacal swabs were immersed
in 1 ml PBS containing antibiotics. VI and titration were performed
according to the EU diagnostic manual (Commission Decision, 2006).
Real-time reverse transcriptase-polymerase chain reaction. Organs were
weighed (0.1 g) and homogenized with sterile quartz sand in 1 ml sterile
PBS to make 1:10 (w/v) dilution.
Extraction of RNA. Two-hundred microlitres of PBS suspension from
homogenated organs, blood and swabs were used to extract the RNA
using a commercial kit (High Pure
TM RNA extraction kit; Roche). RNA
was eluted in a final volume of 60 ml containing 20 u Rnase Inhibitor
(Applied Biosystems) and was stored at 808C.
Real-time reverse transcriptase-polymerase chain reaction. Thirty micro-
litres of RNA solution were retrotranscribed with random hexamers in
a final volume of 60 ml following the instructions of the kit (High
Capacity† cDNA Archive kit; Applied Biosystems). Published primers
and probes (Spackman et al., 2002) targeting the M gene of type A
influenza virus were applied for PCR; namely, forward primer M25
and reverse primer M-124 at the optimized concentration of 300 nM
each, and the specific fluorescent label probe M64 was used at the
final concentration of 250 nM. cDNA was amplified in a final volume
of 25 ml using TaqMan† Universal PCR Master Mix. The PCR
reaction was performed in a ABI Prism 7700 SDS apparatus (Applied
Biosystem) with the following protocol: 2 min at 508C and 10 min at
958C followed by 40 cycles at 958C for 10 sec and 608C for 1 min.
Samples with a threshold cycle value535 were considered positive for
influenza type A viral RNA based on internal validation trials.
Serology. Type and subtype specific antibodies were detected by HI
tests and a ELISA, developed in-house, which utilizes a monoclonal
antibody against the nucleoprotein of type A influenza viruses. For
the HI test, the detection of antibodies to the H7 and H5 subtypes
of AI was performed using 4 haemagglutinating units of the antigens
H5N9 (A/chicken/Italy/22A/1998) and H7N1 (A/chicken/Italy/1067/
1999).
Sera collected from vaccinated animals were considered positive with
an increase in antibody titre in HI tests]4l o g 2 compared with pre-
infection titres. Naı ¨ve animals were considered positive with a
serological titre]4l o g 2.
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Assessment of viral presence in muscles. Unvaccinated
turkeys infected with HPAI virus. Owing to the clinical
condition and subsequent high mortality rate post
challenge, it was not possible to follow the experimental
design for this group, and to collect samples until day 5
p.i. All unvaccinated, HPAI-infected turkeys showed
severe clinical signs starting from day 1 p.i., with 100%
mortality by day 4 p.i. (Table 1). On day 1 p.i., two out of
14 blood samples (one turkey was found dead) yielded
positive results by RRT-PCR. On day 2 p.i., seven out of
11 blood samples were positive; and on day 3 p.i., blood
from all the surviving birds yielded positive results
(Tables 1 and 2). VI confirmed these results. Virus was
detected by RRT-PCR and VI from lung and breast
muscle samples of all dead and killed turkeys, and from
thigh muscles of all but two birds killed humanely on day
1 p.i. (Table 2). The amount of virus varied between 10
1
and 10
4.38 EID50/0.1 g in muscle tissues and from 10
1 to
10
5.8 EID50/0.1 ml in blood (Table 1).
Vaccinated turkeys infected with HPAI virus. No clinical
signs were observed during the experimental trial. No
virus was detected in blood and muscle samples by RRT-
PCRor VI. Virus was detected in lung samples collected
on days 2 and 3 p.i. by both RRT-PCR and VI (Table 3).
Unvaccinated turkeys infected with LPAI virus. Birds
showed mild respiratory disease with depression and
sinusitis starting from day 3 p.i. (Table 4). The results
of VI and RRT-PCR are presented in Table 5. Two
blood samples collected on day 2 p.i. were positive by
RRT-PCR but only one was confirmed by VI (viral titre
B10
1 EID50/0.1 ml). Despite this case of viraemia, no
virus was isolated in muscles.
Vaccinated turkeys infected with LPAI virus. No clinical
signs were observed during the experimental trial and no
virus was detected in lungs and muscles by either VI or
RRT-PCR.
Avian influenza transmission-feeding test. No clinical
signs were observed in any group fed on infective meat.
Neither unvaccinated nor vaccinated birds showed
increased antibody levels. All tracheal and cloacal swabs
collected throughout the experiment yielded negative
results.
Discussion
The results of the challenge study with H7N1 HPAI
indicate that this strain causes viraemia and is able to
reach turkey muscle tissues. These data are in agreement
with the evidence reported that in Galliformes species
Table 1. Clinical signs, schedule of death/sacriﬁcing and time of appearance of viraemia by RRT-PCR of unvaccinated turkeys infected
with HPAI virus A/turkey/Italy/4580/1999 (H7N1)
Turkey number 1 day p.i. 2 days p.i. 3 days p.i. 4 days p.i.
381 Healthy/killed humanely  
382 Healthy/killed humanely viraemic ( B10
1)  
383 Healthy Sick viraemic (B10
1) Dead 
384 Healthy Sick Sick viraemic (10
4.3) Dead
385 Healthy Sick Sick viraemic (10
3.8) Dead
386 Healthy Dead viraemic (10
4.5) 
387 Healthy Dead viraemic (10
5.8) 
388 Healthy/killed humanely viraemic (10
1.25)  
389 Healthy Sick Dead 
390 Healthy Sick viraemic (10
3.6) Sick viraemic (10
1.8) Dead
391 Healthy Sick Sick viraemic (10
4.6) Dead
392 Healthy Sick viraemic (10
2.4) Dead 
393 Healthy Killed humanely viraemic (10
3.5) 
394 Healthy Sick viraemic (10
1.7) Dead 
395 Dead  
Data in parentheses are the viral titre expressed as EID50/0.1 ml.
Table 2. RRT-PCR and VI results in unvaccinated turkeys infected with HPAI virus A/turkey/Italy/4580/1999 (H7N1)
Group 1 day p.i. 2 days p.i. 3 days p.i. 4 days p.i. 5 days p.i.
Virus isolation
Breast 4/4 3/3 4/4 4/4 Not done
Thigh 2/4 3/3 4/4 4/4 Not done
Lung 4/4 3/3 4/4 4/4 Not done
Blood 2/14 7/11 4/4 Not done Not done
RRT-PCR
Breast 4/4 3/3 4/4 4/4 Not done
Thigh 2/4 3/3 4/4 4/4 Not done
Lung 4/4 3/3 4/4 4/4 Not done
Blood 2/14 7/11 4/4 Not done Not done
Data presented as number positive/total.
HPAI and LPAI in turkey meat 409HPAI viruses cause viraemia and systemic infection and
virus can be detected in the muscle tissues of infected
birds. Several studies have shown that HPAI viruses may
be recovered from meat of chickens, turkeys (Perkins &
Swayne, 2001; Kishida et al., 2004; Swayne & Beck,
2005; Swayne, 2006) and ducks (Tumpey et al., 2002,
2003; Lu et al., 2003; Beato et al., 2007) following both
field and experimental infection.
In addition to the existing data we evaluated the trend
of viraemia, showing high levels of viable virus in blood
during the first 3 days p.i. with HPAI virus, which
correspond to high levels of virus in muscles.
With reference to the H7N1 LPAI virus reported here,
infection results show the ability of this strain to cause
viraemia in turkeys, although in a limited number of
birds. This information is in contrast with the general
consensus that LPAI viruses cause a strictly localized
infection without viraemia, and is in keeping with the
clinical condition developed by some birds following
natural and experimental infection. There is only one
precedent report of LPAI virus causing viraemia:
Kishida et al. (2004) described the isolation of two
H9N2 strains from imported chicken meat and bone
marrow. In their investigation, Kishida et al.w e r ea b l et o
detect virus in blood, bone marrow and muscles of
chickens infected experimentally with those viruses. Our
findings differ from those obtained by Swayne & Beck
(2005), who failed to detect LPAI viruses (H7N2) in the
blood of chickens infected experimentally. However, this
difference could be due to the strain variability and to
host susceptibility.
In any case, despite the detection of viable virus from
the blood, no virus was isolated from muscles of the
unvaccinated LPAI-infected turkeys, although positive
RRT-PCR results suggest that virus can reach muscle
tissues.
In the present paper we report the absence of
detectable virus in the blood and in meat of vaccinated
turkeys infected with both LPAI and HPAI viruses. This
evidence suggests that vaccination is an effective tool for
preventing viraemia and, as a consequence, preventing
meat from infected turkeys being infective.
Under experimental conditions, transmission of HPAI
infection to naı ¨ve or vaccinated birds through the
administration of 2 g meat homogenate containing
10
3.6 EID50/0.1 g failed, and therefore no transmission
of infection could be expected from meat of vaccinated
birds that, both by RRT-PCR and by VI, appeared to
contain no virus.
It is noteworthy that viable virus was recovered from
the lungs of vaccinated turkeys challenged with HPAI
virus. These data are in agreement with studies con-
ducted by Swayne & Beck (2005), who detected viable
LPAI H7N2 subtype virus from fluid collected post
evisceration following internal body cavity wash. These
findings suggest that contamination of the carcass with
internal organ exudates could represent a means by
which LPAI can be introduced into a country through
legal trade. It can be concluded that even if no virus was
Table 3. RRT-PCR and VI results in vaccinated turkeys infected with HPAI virus A/turkey/Italy/4580/1999 (H7N1)
Group 1 day p.i. 2 days p.i. 3 days p.i. 4 days p.i. 5 days p.i.
Virus isolation
Breast 0/3 0/3 0/3 0/3 0/3
Thigh 0/3 0/3 0/3 0/3 0/3
Lung 0/3 1/3 2/3 0/3 0/3
Blood 0/15 0/12 0/9 0/6 0/3
RRT-PCR
Breast 0/3 0/3 0/3 0/3 0/3
Thigh 0/3 0/3 0/3 0/3 0/3
Lung 0/3 1/3 2/3 0/3 0/3
Blood 0/15 0/12 0/9 0/6 0/3
Data presented as number positive/total.
Table 4. Clinical signs and schedule of sacriﬁcing and time of appearance of viraemia by RRT-PCR of unvaccinated turkeys infected
with LPAI virus A/turkey/Italy/3675/1999 (H7N1)
Turkey number 1 day p.i. 2 days p.i. 3 days p.i. 4 days p.i. 5 days p.i.
341 Healthy Killed humanely viraemic 
342 Healthy Healthy Killed humanely 
343 Healthy Healthy Sick/killed humanely 
344 Healthy Killed humanely viraemic 
345 Healthy Healthy Sick Sick/killed humanely 
346 Healthy Killed humanely 
347 Healthy Healthy Sick Killed humanely 
348 Killed humanely   
349 Healthy Healthy Sick Sick Killed humanely
350 Killed humanely   
352 Healthy Healthy Healthy Healthy Killed humanely
353 Healthy Healthy Sick/killed humanely 
354 Healthy Healthy Healthy Sick Killed humanely
355 Healthy Healthy Healthy Killed humanely 
400 Killed humanely   
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turkeys, bird carcasses can still represent a potential
vehicle of infection if the hygienic conditions at the
slaughterhouse are poor. For these reasons it appears
reasonable to recommend that in poultry slaughter-
houses special attention should be paid to treat carcass
wash fluids properly and to completely eviscerate
carcasses. It would, in any case, be logical to assume
that the titre of the contaminating virus would not be
high enough to generate a secondary cycle of infection if
it were introduced in the animal food chain as swill
feeding, giving the low initial titres and the dilution
effect occurring during processing.
Several experimental studies highlight the possibility
of AI transmission trough the consumption of untreated
infective meat. Purchase (1931) and Swayne & Beck
(2005) showed that chickens fed on muscle tissues from
HPAI-infected birds can become infected. On the basis
of these previous investigations we tested the role that
untreated infective meat may play in the transmission of
AI viruses to vaccinated and unvaccinated chickens and
turkeys. The results obtained with the transmission-
feeding test indicate that infection by feeding birds with
infective meat was achieved in neither unvaccinated nor
vaccinated birds, and it can be suggested that a higher
dose of virus is required to cause the infection by the
oral route.
The results reported in the present study suggest that
vaccination prevents viraemia and viral localization in
turkey muscles and thus minimizes the potential of meat
as vehicle for transmission of HPAI and LPAI viruses of
the H7 subtype.
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